XML 35 R21.htm IDEA: XBRL DOCUMENT
v3.4.0.3

SEGMENT AND ENTERPRISE-WIDE INFORMATION | 12 Months Ended
--- | ---
Apr. 02, 2016
Segment Reporting [Abstract] |
SEGMENT AND ENTERPRISE-WIDE INFORMATION | SEGMENT AND ENTERPRISE-WIDE INFORMATION We determine our reportable segments by first identifying our operating segments, and then by assessing whether any components of these segments constitute a business for which discrete financial information is available and where segment management regularly reviews the operating results of that component. Our operating segments are based primarily on geography. North America Plasma is a separate operating segment with dedicated segment management due the size and scale of the plasma business. We aggregate components within an operating segment that have similar economic characteristics. In prior periods, the Company believed a single reportable segment was consistent with its basic organizational structure and believed aggregation was consistent with its primary basis for decision making. As a result, prior year segment information has been restated to conform to fiscal 2016's reportable segments. The Company’s reportable segments are as follows:
• | Japan
• | Europe, Middle East and Africa (collectively “EMEA”)
• | North America Plasma
• | All Other
The Company has aggregated the following two operating segments into the All Other reportable segment based upon their similar operational and economic characteristics, including similarity of operating margin:
• | Americas Blood Center and Hospital
• | Asia - Pacific
Management measures and evaluates the Company’s operating segments based on operating margin. Management excludes certain corporate expenses from segment operating income. In addition, certain amounts that management considers to be non-recurring or non-operational are excluded from segment operating income because management evaluates the operating results of the segments excluding such items. These items include restructuring and transformation costs, deal amortization, impairments and other (income)/expense associated with certain acquisitions. Although these amounts are excluded from segment operating income, as applicable, they are included in the reconciliations that follow. Segment assets have not been presented since management does not evaluate the Company’s operating segments using this information. Further, management measures and evaluates the Company's net revenues and operating income on a constant currency basis, therefore segment information is presented on a constant currency basis. Selected information by business segment is presented below:
(In thousands) | April 2, 2016 |  | March 28, 2015 |  | March 29, 2014
Net revenues |  |  |  |  |
Japan | $ | 84,270 |  |  | $ | 83,547 |  |  | $ | 89,041 |
EMEA | 175,874 |  |  | 183,753 |  |  | 193,691 |
North America Plasma | 279,803 |  |  | 240,705 |  |  | 213,215 |
All Other | 370,568 |  |  | 375,827 |  |  | 400,133 |
Net revenues (constant currency) | 910,515 |  |  | 883,832 |  |  | 896,080 |
Effect of exchange rates | (1,683 | ) |  | 26,541 |  |  | 42,429 |
Net revenues (reported) | $ | 908,832 |  |  | $ | 910,373 |  |  | $ | 938,509 |
(In thousands) | April 2, 2016 |  | March 28, 2015 |  | March 29, 2014
Segment operating income |  |  |  |  |
Japan | $ | 37,165 |  |  | $ | 36,843 |  |  | $ | 38,685 |
EMEA | 36,976 |  |  | 44,998 |  |  | 49,373 |
North America Plasma | 100,367 |  |  | 89,092 |  |  | 82,497 |
All Other | 135,580 |  |  | 142,531 |  |  | 154,099 |
Segment operating income (constant currency) | 310,088 |  |  | 313,464 |  |  | 324,654 |
Corporate operating expenses (constant currency) | (194,361 | ) |  | (189,867 | ) |  | (186,562 | )
Non-GAAP operating income (constant currency) | 115,727 |  |  | 123,597 |  |  | 138,092 |
Effect of exchange rates | 3,977 |  |  | 13,906 |  |  | 21,147 |
Non-GAAP operating income (reported) | 119,704 |  |  | 137,503 |  |  | 159,239 |
Unallocated amounts |  |  |  |  |
Restructuring and transformation costs | 42,185 |  |  | 69,697 |  |  | 84,706 |
Deal amortization | 28,958 |  |  | 30,184 |  |  | 28,056 |
Impairment of assets | 97,230 |  |  | — |  |  | — |
Contingent consideration (income) expense | (4,727 | ) |  | (2,918 | ) |  | 45 |
Operating (loss) income | $ | (43,942 | ) |  | $ | 40,540 |  |  | $ | 46,432 |
(In thousands) | April 2, 2016 |  | March 28, 2015 |  | March 29, 2014
Depreciation and amortization |  |  |  |  |
Japan | $ | 774 |  |  | $ | 767 |  |  | $ | 839 |
EMEA | 5,146 |  |  | 5,045 |  |  | 4,695 |
North America Plasma | 12,944 |  |  | 11,229 |  |  | 8,776 |
All Other | 71,047 |  |  | 69,012 |  |  | 67,430 |
Total depreciation and amortization (excluding impairment charges) | $ | 89,911 |  |  | $ | 86,053 |  |  | $ | 81,740 |
(In thousands) | April 2, 2016 |  | March 28, 2015 |  | March 29, 2014
Long-lived assets(1) |  |  |  |  |
Japan | $ | 33,159 |  |  | $ | 31,810 |  |  | $ | 28,544 |
EMEA | 63,861 |  |  | 66,223 |  |  | 59,034 |
North America Plasma | 116,001 |  |  | 101,272 |  |  | 75,597 |
All Other | 124,613 |  |  | 122,643 |  |  | 108,262 |
Total long-lived assets | $ | 337,634 |  |  | $ | 321,948 |  |  | $ | 271,437 |
(1)Long-lived assets are comprised of property, plant and equipment. Long-lived assets in our principle operating regions are as follows:
| April 2, 2016 |  | March 28, 2015 |  | March 29, 2014
United States | $ | 231,744 |  |  | $ | 208,439 |  |  | $ | 185,227 |
Japan | 2,022 |  |  | 1,618 |  |  | 2,563 |
Europe | 18,672 |  |  | 27,786 |  |  | 37,154 |
Asia | 40,235 |  |  | 39,032 |  |  | 8,785 |
Other | 44,961 |  |  | 45,073 |  |  | 37,708 |
Total | $ | 337,634 |  |  | $ | 321,948 |  |  | $ | 271,437 |
Net revenues by product line are as follows:
(In thousands) | April 2, 2016 |  | March 28, 2015 |  | March 29, 2014
Disposable revenues |  |  |  |  |  |  |  |
Plasma disposables | $ | 348,785 |  |  | $ | 319,190 |  |  | $ | 291,895 |
Blood center disposables |  |  |  |  |  |  |  |
Platelet | 143,274 |  |  | 152,588 |  |  | 156,643 |
Red cell | 39,256 |  |  | 42,700 |  |  | 42,378 |
Whole blood | 128,532 |  |  | 143,905 |  |  | 190,698 |
| 311,062 |  |  | 339,193 |  |  | 389,719 |
Hospital disposables |  |  |  |  |  |  |  |
Diagnostics | 50,882 |  |  | 42,187 |  |  | 33,302 |
Surgical | 59,902 |  |  | 62,540 |  |  | 66,876 |
OrthoPAT | 13,823 |  |  | 20,316 |  |  | 25,042 |
| 124,607 |  |  | 125,043 |  |  | 125,220 |
Disposables revenue | 784,454 |  |  | 783,426 |  |  | 806,834 |
Software solutions | 72,434 |  |  | 72,185 |  |  | 70,441 |
Equipment & other | 51,944 |  |  | 54,762 |  |  | 61,234 |
Net revenues | $ | 908,832 |  |  | $ | 910,373 |  |  | $ | 938,509 |
Net revenues generated in our principle operating regions are as follows:
| April 2, 2016 |  | March 28, 2015 |  | March 29, 2014
United States | $ | 519,440 |  |  | $ | 494,788 |  |  | $ | 500,719 |
Japan | 81,411 |  |  | 88,298 |  |  | 108,679 |
Europe | 187,725 |  |  | 215,575 |  |  | 224,792 |
Asia | 111,758 |  |  | 102,095 |  |  | 94,762 |
Other | 8,498 |  |  | 9,617 |  |  | 9,557 |
Total | $ | 908,832 |  |  | $ | 910,373 |  |  | $ | 938,509 |

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8981-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9038-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 33 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8971-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8595-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8380-108599 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 35 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8984-108599 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9031-108599 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9054-108599 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8538-108599 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 29 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8864-108599 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration